Prognostic and predictive significance of multidrug resistance-associated protein 2 (MRP2) expression and its subcellular localization in breast cancer

被引：0
|
作者：
Matkowski, R. [1 ,2 ]
Szynglarewicz, B. [1 ]
Gisterek, I. [2 ]
Kornafel, J. [2 ]
Halon, A. [3 ]
机构：
[1] Wroclaw Med Univ, Lower Silesian Oncol Ctr, Dept Surg Oncol 2, Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Oncol, Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Pathomorphol, Wroclaw, Poland
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
10.1016/S0960-9776(11)70129-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer
    K Nooter
    G Brutel de la Riviere
    MP Look
    KE van Wingerden
    SC Henzen-Logmans
    RJ Scheper
    MJ Flens
    JGM Klijn
    G Stoter
    JA Foekens
    British Journal of Cancer, 1997, 76 : 486 - 493
  • [2] Regulation of multidrug resistance-associated protein 2 (MRP2) by dehydroepiandrosterone and its conjugates
    Han, Yong-Hae
    Chen, Cliff
    Wang, Bonnie
    Yang, Zheng
    Marathe, Punit
    Rodrigues, David
    DRUG METABOLISM REVIEWS, 2006, 38 : 226 - 226
  • [3] Comparative analysis of human multidrug resistance-associated protein 2 (MRP2) and rat MRP2
    Krajcsi, P
    Glavinas, H
    Kis, E
    Kovács, R
    Pál, A
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 25 : S17 - S18
  • [4] Expression of MRP2 (multidrug resistance-associated protein2) regulates the drug resistance of human pancreatic cancer
    Noma, Bunjiro
    Sasaki, Tamito
    Fujimoto, Yoshifumi
    Kuwahara, Kenichi
    Serikawa, Masahiro
    Kobayashi, Kenso
    Ituki, Hiroshi
    Chayama, Kazuaki
    GASTROENTEROLOGY, 2008, 134 (04) : A454 - A454
  • [5] Quantitative immunofluorescent blotting of the Multidrug Resistance-associated Protein 2 (MRP2)
    Gerk, Phillip M.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2011, 63 (03) : 279 - 282
  • [6] Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2
    Ninomiya, M
    Ito, K
    Horie, T
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (02) : 225 - 232
  • [7] Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2)
    Lindenmaier, H
    Becker, M
    Haefeli, WE
    Weiss, J
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (11) : 1576 - 1579
  • [8] The prognostic significance of expression of the multidrug resistance associated protein (MRP) in primary breast cancer
    Nooter, K
    delaRiviere, GB
    Look, MP
    vanWingerden, KE
    HenzenLogmans, SC
    Scheper, RJ
    Flens, MJ
    Klijn, JGM
    Stoter, G
    Foekens, JA
    BRITISH JOURNAL OF CANCER, 1997, 76 (04) : 486 - 493
  • [9] Noncholestatic estrogen glucuronides interact with the multidrug resistance-associated protein 2 (Mrp2)
    Gerk, PM
    Li, W
    Vore, M
    FASEB JOURNAL, 2003, 17 (05): : A1027 - A1027
  • [10] Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2)
    Ninomiya, Mizuki
    Ito, Kousei
    Hiramatsu, Remi
    Horie, Toshiharu
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (12) : 2056 - 2063
12345